Mirna Therapeutics has appointed Clay Siegall as an outside director on its board.
Siegall is the co-founder, president, and CEO of Seattle Genetics. He previously held various positions with Bristol-Myers Squibb and the National Cancer Institute.
People in the News: Clay Siegall
Premium